Twenty years ago, a pioneering team of clinicians and engineers had a vision to use a mechanical heart-assist device as an aid to a patient with a failing heart, and to ascertain if such a heart assist device could serve as a “bridge” for an ailing heart until a transplantable organ became available.
While the team consisted of many diverse disciplines, the lead biomedical engineer was Dr. Harvey Borovetz. In this interview, Dr. Borovetz provides a retrospective look at the initial days of what has become a relatively routine clinical procedure to support a weakened heart with a ventricular assist device until a heart transplant can be implemented. Dr. Borovetz shares the progress that has been made in the engineering as well as the clinical procedures.
He also provides a glimpse at the future, sharing his vision on the emerging technology development that he is leading to provide equivalent cardiac care for infants and children.
For more information, the following web sites may be of interest:
Hosts Leah Kauffman and John Murphy. Interview by Leah Kauffman.
For more information about the McGowan Institute for Regenerative Medicine, visit: